Lifeon Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 121 million yuan, a year-on-year increase of 1.65%Zhitong·Oct 29, 2025 at 03:49 AM003020+4.39%
A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%Zhitong·Sep 9, 2025 at 01:19 AM688356+0.43%603127+3.72%
Lifeon Pharmaceutical: Gao Meihua reduced her stake by 0.16%Zhitong·Sep 2, 2025 at 07:14 AM003020+4.39%
Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoonZhitong·Sep 1, 2025 at 12:54 AM003020+4.39%301096+5.17%
Lifeon Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53%Zhitong·Aug 25, 2025 at 05:37 AM003020+4.39%
The chemical pharmaceutical sector fluctuated and weakened, with TIBET AIM PHARM hitting the limit down, followed by Lifeon Pharmaceutical, JLPC, huahaipharm, Foyou Pharma, and CHENGYIPHARMAZhitong·Aug 20, 2025 at 09:08 PM002826+3.87%003020+4.39%
The innovative drug sector surged in the short term, with Chimin hitting the daily limitZhitong·Aug 18, 2025 at 08:32 PM603222+2.29%002873+2.54%
Lifeon Pharmaceutical: Mesalazine enteric-coated tablets complete drug registrationZhitong·Jul 31, 2025 at 05:03 AM003020+4.39%
Lifeon Pharmaceutical: The application for the listing of the chemical raw material drug Procaine Hydrochloride has been approvedZhitong·Jul 29, 2025 at 03:20 AM003020+4.39%
Lifeon Pharmaceutical: The listing application for the chemical raw material Danpi Phenol has been approvedZhitong·Jun 30, 2025 at 03:01 AM003020+4.39%
Lifeon Pharmaceutical: Sodium Docetaxel has received approval for the active pharmaceutical ingredient listing applicationZhitong·May 28, 2025 at 05:22 AM003020+4.39%
Lifeon Pharmaceutical plans to recover investment costs by transferring 2.22% equity in MainoweiZhitong·May 12, 2025 at 08:29 AM003020+4.39%
Lifeon Pharmaceutical: Methylphenidate Hydrochloride Extended-Release Tablets are expected to be launched by the end of the third quarter of this yearZhitong·May 5, 2025 at 10:55 PM003020+4.39%
Lifeon Pharmaceutical: Received the Clinical Trial Approval Notice for DrugsZhitong·Apr 24, 2025 at 04:30 AM003020+4.39%
Lifeon Pharmaceutical: Obtained the drug registration certificate for Timolol Maleate Eye DropsZhitong·Apr 22, 2025 at 05:05 AM003020+4.39%
